These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1638761)

  • 1. Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice.
    Baeder WL; Sredy J; Sehgal SN; Chang JY; Adams LM
    Clin Exp Immunol; 1992 Aug; 89(2):174-8. PubMed ID: 1638761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
    Choi MS; Jung UJ; Yeo J; Kim MJ; Lee MK
    Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
    Joffe I; Katz I; Sehgal S; Bex F; Kharode Y; Tamasi J; Epstein S
    Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
    Nicoletti F; Zaccone P; Di Marco R; Magro G; Grasso S; Morrone S; Santoni A; Tempera G; Meroni PL; Bendtzen K
    Immunology; 1995 Aug; 85(4):645-50. PubMed ID: 7558161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration.
    Meyerovitch J; Waner T; Sack J; Kopolovic J; Shemer J
    Isr Med Assoc J; 2000 Mar; 2(3):211-4. PubMed ID: 10774269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin, a potential disease-modifying antiarthritic drug.
    Carlson RP; Hartman DA; Tomchek LA; Walter TL; Lugay JR; Calhoun W; Sehgal SN; Chang JY
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1125-38. PubMed ID: 8355184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice.
    Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Fujii M; Ohashi K; Ikeda M; Kurimoto M
    J Interferon Cytokine Res; 1999 Aug; 19(8):877-9. PubMed ID: 10476932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A; Bastos MG; Muggia RA; Pankewycz O; Nichols J; Murphy JR; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1992 Mar; 22(3):697-702. PubMed ID: 1547815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases.
    Carlson RP; Baeder WL; Caccese RG; Warner LM; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():86-113. PubMed ID: 8363289
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM.
    Bowman MA; Campbell L; Darrow BL; Ellis TM; Suresh A; Atkinson MA
    Diabetes; 1996 Feb; 45(2):205-8. PubMed ID: 8549866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type I diabetes in the non-obese diabetic (NOD) mouse with 15-deoxyspergualin (15-DS) or 15-DS + cyclosporin A (CyA).
    Haberstroh J; Wilhelm T; Schulte-Mönting J; Schorlemmer HU; von Specht BU
    Immunol Lett; 1995 Dec; 48(2):117-21. PubMed ID: 8719109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.
    Tahvili S; Törngren M; Holmberg D; Leanderson T; Ivars F
    PLoS One; 2018; 13(5):e0196598. PubMed ID: 29742113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rapamycin on kidney function in the Sprague-Dawley rat.
    DiJoseph JF; Sharma RN; Chang JY
    Transplantation; 1992 Mar; 53(3):507-13. PubMed ID: 1549839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F; Di Marco R; Barcellini W; Magro G; Schorlemmer HU; Kurrle R; Lunetta M; Grasso S; Zaccone P; Meroni P
    Eur J Immunol; 1994 Aug; 24(8):1843-7. PubMed ID: 8056041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.